APC anti-mouse CD62L Antibody

Pricing & Availability
Clone
MEL-14 (See other available formats)
Regulatory Status
RUO
Other Names
L-selectin, LECAM-1, Ly-22, LAM-1, MEL-14
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
MEL-14_APC_090707
C57BL/6 mouse splenocytes were stained with CD62L (clone MEL-14) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
  • MEL-14_APC_090707
    C57BL/6 mouse splenocytes were stained with CD62L (clone MEL-14) APC (filled histogram) or rat IgG2a, κ APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
104411 25 µg 53€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104412 100 µg 155€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD62L is a 74-95 kD glycoprotein also known as L-selectin, LECAM-1, Ly-22, LAM-1, and MEL-14. It is a member of the selectin family and is expressed on the majority of B and naïve T cells, a subset of memory T cells, monocytes, granulocytes, most thymocytes, and a subset of NK cells. CD62L is important in lymphocyte homing to high endothelial venules (HEV) in peripheral lymph nodes and leukocyte "rolling" on activated endothelium. CD62L also contributes to neutrophil emigration at inflammatory sites. CD62L is rapidly shed from lymphocytes and neutrophils upon cellular activation and the expression levels of CD62L (in conjunction with other markers) have been used to distinguish naïve, effector, and memory T cells. CD62L has been reported to interact with CD34, GlyCAM-1, and MAdCAM-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C3H/eb mouse B lymphoma 38C-13
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1-3, complement-dependent cytotoxicity4, in vivo and in vitro blocking of adhesion1-3,5, and immunohistochemical staining of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections6. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104457-104462).

Application References

(PubMed link indicates BioLegend citation)
  1. Gallatin WM, et al. 1983. Nature 304:30. (IP, Block)
  2. Siegelman MH, et al. 1990. Cell 61:611. (IP, Block)
  3. Lewinsohn DM, et al. 1987. J. Immunol. 138:4313. (IP, Block)
  4. Iwabuchi K, et al. 1991. Immunobiology 182:161. (CMCD)
  5. Pizcueta P, et al. 1994. Am. J. Pathol. 145:461.
  6. Reichert RA, et al. 1986. J. Immunol. 136:3535. (IHC, FC)
  7. Olver S, et al. 2006. Cancer Res. 66:571.
  8. Fukushima A, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:657. PubMed
  9. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  10. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed
  11. Lee JW, et al. 2006. Nature Immunol. 8:181.
  12. Shigeta A, et al. 2008. Blood 112:4915 (FC) PubMed
  13. de Vries VC, et al. 2009. Am. J. Transplant. 9:2270 PubMed
Product Citations
  1. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  2. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  3. Cowan J, et al. 2013. J Exp Med. 210:675. PubMed
  4. Ender F, et al. 2017. PLoS One. 12(2):e0172446. PubMed
  5. Sun L, et al. 2021. Cancer Cell. :. PubMed
  6. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  7. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  8. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  9. Martens R, et al. 2020. Nat Commun. 11:1114. PubMed
  10. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  11. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  12. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  13. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  14. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  15. Wang J, et al. 2012. Blood. 120:1489. PubMed
  16. Wei H, et al. 2021. Malar J. 20:89. PubMed
  17. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  18. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  19. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  20. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  21. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  22. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  23. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  24. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  25. Zhao Y, et al. 2021. J Biol Chem. 297:101166. PubMed
  26. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  27. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  28. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  29. Wiese A, et al. 2017. PLoS One. 10.1371/journal.pone.0184956. PubMed
  30. Roy S, et al. 2020. Sci Rep. 10:10992. PubMed
  31. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  32. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  33. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  34. Parriott G, et al. 2020. Immunology. 160:280. PubMed
  35. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  36. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  37. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  38. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  39. Ma X et al. 2019. Cell Metab. 30(1):143-156 . PubMed
  40. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  41. Deng B, et al. 2022. J Immunother Cancer. 10:. PubMed
  42. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  43. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  44. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  45. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  46. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  47. Darragh LB, et al. 2022. Nat Commun. 13:7015. PubMed
  48. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  49. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  50. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  51. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  52. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  53. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  54. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  55. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  56. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  57. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  58. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  59. Cowan J, et al. 2014. J Immunol. 193:1204. PubMed
  60. White C, et al. 2015. J Immunol. 194:697. PubMed
  61. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  62. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  63. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  64. Morimoto Y, et al. 2018. Immunity. 49:134. PubMed
  65. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  66. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  67. Ma K, et al. 2022. iScience. 25:104347. PubMed
  68. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  69. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  70. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  71. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  72. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  73. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  74. Do-Thi VA, et al. 2021. Cancers (Basel). 13:. PubMed
  75. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  76. Resch TK, et al. 2018. Sci Rep. 0.722916667. PubMed
  77. Jenkinson W, et al. 2012. PLoS One. 7:e53416. PubMed
  78. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  79. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  80. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  81. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  82. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  83. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  84. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  85. Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
  86. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  87. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  88. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  89. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  90. Webb LM, et al. 2020. J Clin Invest. 130:1683. PubMed
  91. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  92. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  93. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  94. Lin JD, et al. 2020. Cell Host & Microbe. 27(5):830-840. PubMed
  95. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  96. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  97. Kooijman S, et al. 2015. Am J Physiol Heart Circ Physiol. 309: H646-H654. PubMed
  98. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  99. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  100. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  101. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  102. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  103. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
  104. Louise V Webb et al. 2019. Immunity. 50(2):348-361 . PubMed
  105. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  106. Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed
RRID
AB_313098 (BioLegend Cat. No. 104411)
AB_313099 (BioLegend Cat. No. 104412)

Antigen Details

Structure
Selectin, 95 kD (neutrophils) or 74 kD (lymphocytes)
Distribution

Subsets of B and T cells, monocytes, granulocytes, subset of NK cells

Function
Lymphocyte homing to HEV, rolling on activated endothelium
Ligand/Receptor
CD34, GlyCAM-1, MAdCAM-1
Cell Type
B cells, Granulocytes, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Kishimoto TK, et al. 1990. P. Natl. Acad. Sci. USA 87:2244.
3. Tedder TF, et al. 1995. J. Exp. Med. 181:2259.

Gene ID
20343 View all products for this Gene ID
UniProt
View information about CD62L on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD62L

  • Biotin anti-mouse CD62L

  • FITC anti-mouse CD62L

  • PE anti-mouse CD62L

  • PE/Cyanine5 anti-mouse CD62L

  • Purified anti-mouse CD62L

  • PE/Cyanine7 anti-mouse CD62L

  • Alexa Fluor® 488 anti-mouse CD62L

  • Alexa Fluor® 647 anti-mouse CD62L

  • Pacific Blue™ anti-mouse CD62L

  • Alexa Fluor® 700 anti-mouse CD62L

  • APC/Cyanine7 anti-mouse CD62L

  • PerCP/Cyanine5.5 anti-mouse CD62L

  • PerCP anti-mouse CD62L

  • Brilliant Violet 421™ anti-mouse CD62L

  • Brilliant Violet 570™ anti-mouse CD62L

  • Brilliant Violet 605™ anti-mouse CD62L

  • Brilliant Violet 510™ anti-mouse CD62L

  • Purified anti-mouse CD62L (Maxpar® Ready)

  • Brilliant Violet 711™ anti-mouse CD62L

  • Brilliant Violet 785™ anti-mouse CD62L

  • PE/Dazzle™ 594 anti-mouse CD62L

  • APC/Fire™ 750 anti-mouse CD62L

  • TotalSeq™-A0112 anti-mouse CD62L

  • Brilliant Violet 650™ anti-mouse CD62L

  • TotalSeq™-C0112 anti-mouse CD62L

  • Ultra-LEAF™ Purified anti-mouse CD62L

  • KIRAVIA Blue 520™ anti-mouse CD62L

  • TotalSeq™-B0112 anti-mouse CD62L

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account